Search Within

Patrizia Mondello

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (12)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (38)
  2. Department of Medicine (24)
  3. Hematologic Malignancies, Division of (24)
  4. Center for Hematologic Malignancies (19)
  5. Lymphoma (16)
  6. Executive Committee, Center for Hematologic Malignancies (13)

More Groups

People
  1. Anas Younes (11)
  2. Gilles Salles (8)
  3. Venkatraman Seshan (8)
  4. Andrew Zelenetz (6)
  5. David Scheinberg (6)
  6. Elisa De Stanchina (6)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (9)
  6. 2019 (3)

More Years

Publications
  1. Blood (9)
  2. Blood Cancer Journal (3)
  3. Oncotarget (3)
  4. Annals of Hematology (2)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (4)
  4. Impact Journals (3)
  5. Springer (3)
  6. Elsevier Inc. (2)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting of PIM kinases shows single agent efficacy and synergizes with BCL2 inhibitors in diffuse large B cell lymphoma of the ABC subtype
    Journal Article

    Tarantelli, C.; Kayali, O.; Civanelli, E.; Cascione, L.; Mensah, A. A.; Folloni, C.; Arribas, A. J.; Rinaldi, A.; Cmiljanovic, V.; Mondello, P.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • RE-MIND2: Comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Annals of Hematology (2023)

    Fulltext@MSK | Save
  • Interim positron emission tomography during frontline chemoimmunotherapy for follicular lymphoma
    Journal Article

    Merryman, R. W.; Michaud, L.; Redd, R.; Mondello, P.; Park, H.; Spilberg, G.; Robertson, M.; Taranto, E.; Ahmed, G.; Chase, M.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Inhibition of NF-κB DNA binding suppresses myeloma growth via intracellular redox and tumor microenvironment modulation
    Journal Article

    Bariana, M.; Cassella, E.; Rateshwar, J.; Ouk, S.; Liou, H. C.; Heller, C.; Colorado, I.; Feinman, R.; Makhdoom, A.; Siegel, D. S.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Peters, A.; Mondello, P.; Joffe, E.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tafasitamab plus lenalidomide versus pola-BR, R2, and CAR T: Comparing outcomes from RE-MIND2, an observational, retrospective cohort study in relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Fleury, I.; Peters, A.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Overall survival with tafasitamab + lenalidomide (LEN) vs routinely administered therapies for ASCT-ineligible relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Outcomes from the observational RE-MIND2 study
    Meeting Abstract

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Lack of intrafollicular memory CD4+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
    Journal Article

    Mondello, P.; Fama, A.; Larson, M. C.; Feldman, A. L.; Villasboas, J. C.; Yang, Z. Z.; Galkin, I.; Svelolkin, V.; Postovalova, E.; Bagaev, A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Journal Article

    Bobillo, S.; Joffe, E.; Sermer, D.; Mondello, P.; Ghione, P.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • High dimensional tissue-based spatial analysis of the tumor microenvironment of follicular lymphoma reveals unique immune niches inside malignant follicles
    Meeting Abstract

    Villasboas, J. C.; Mondello, P.; Fama, A.; Larson, M. C.; Feldman, A. L.; Yang, Z. Z.; Galkin, I.; Svekolkin, V.; Postovalova, E.; Bagaev, A.; more...
    Blood (2020)

    Fulltext@MSK | Save